Answers are grounded in this paper and cite their sources.
Evaluates antioxidant and enzyme-modulatory effects of Opopanax hispidus extracts in diabetes, suggesting natural management strategies.
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia and oxidative stress, contributing to long-term complications. Opopanax hispidus (Apiaceae) is a perennial aromatic plant used in traditional medicine, yet its antidiabetic potential remains largely unexplored. This study evaluated the antioxidant and α-glucosidase inhibitory activities of aqueous and methanolic extracts of O. hispidus aerial parts. Phenolic and flavonoid contents were analyzed by HPLC, identifying kaempferol, rutin, luteolin, chlorogenic acid, and p-coumaric acid. Antioxidant activity was assessed via DPPH and ABTS radical scavenging assays, showing higher DPPH activity for the aqueous extract (87.55% at 5 mg/mL) than the methanolic extract (65.39%), while both exhibited similar ABTS inhibition (~87–88%). In vitro α-glucosidase inhibition revealed dose-dependent activity, with the methanolic extract reaching 67.18% inhibition at 5 mg/mL and the aqueous extract showing more consistent inhibition across concentrations (59.88% at 5 mg/mL). These findings indicate that O. hispidus extracts are rich in bioactive phenolics and display strong antioxidant and moderate α-glucosidase inhibitory effects, suggesting potential as natural agents for managing postprandial glycemia. Further in vivo studies are warranted to clarify the molecular mechanisms and therapeutic relevance of these extracts.
No takes yet. Share an insight, caveat, or question.
Aydın et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: